Unknown

Dataset Information

0

Structural stability of human protein tyrosine phosphatase ? catalytic domain: effect of point mutations.


ABSTRACT: Protein tyrosine phosphatase ? (PTP?) belongs to the classical receptor type IIB family of protein tyrosine phosphatase, the most frequently mutated tyrosine phosphatase in human cancer. There are evidences to suggest that PTP? may act as a tumor suppressor gene and dysregulation of Tyr phosphorylation can be observed in diverse diseases, such as diabetes, immune deficiencies and cancer. PTP? variants in the catalytic domain have been identified in cancer tissues. These natural variants are nonsynonymous single nucleotide polymorphisms, variations of a single nucleotide occurring in the coding region and leading to amino acid substitutions. In this study we investigated the effect of amino acid substitution on the structural stability and on the activity of the membrane-proximal catalytic domain of PTP?. We expressed and purified as soluble recombinant proteins some of the mutants of the membrane-proximal catalytic domain of PTP? identified in colorectal cancer and in the single nucleotide polymorphisms database. The mutants show a decreased thermal and thermodynamic stability and decreased activation energy relative to phosphatase activity, when compared to wild- type. All the variants show three-state equilibrium unfolding transitions similar to that of the wild- type, with the accumulation of a folding intermediate populated at ~4.0 M urea.

SUBMITTER: Pasquo A 

PROVIDER: S-EPMC3289658 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural stability of human protein tyrosine phosphatase ρ catalytic domain: effect of point mutations.

Pasquo Alessandra A   Consalvi Valerio V   Knapp Stefan S   Alfano Ivan I   Ardini Matteo M   Stefanini Simonetta S   Chiaraluce Roberta R  

PloS one 20120228 2


Protein tyrosine phosphatase ρ (PTPρ) belongs to the classical receptor type IIB family of protein tyrosine phosphatase, the most frequently mutated tyrosine phosphatase in human cancer. There are evidences to suggest that PTPρ may act as a tumor suppressor gene and dysregulation of Tyr phosphorylation can be observed in diverse diseases, such as diabetes, immune deficiencies and cancer. PTPρ variants in the catalytic domain have been identified in cancer tissues. These natural variants are nons  ...[more]

Similar Datasets

| S-EPMC3887927 | biostudies-literature
| S-EPMC2242534 | biostudies-literature
| S-EPMC6017198 | biostudies-literature
| S-EPMC3172300 | biostudies-literature